[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
OEM: Carcinoid tumour of thymus and radioisotope exposure
Here is case that we would appreciate your comments on:
We have just seen a 46 year old man who was employed from
1969 to 1978 as an oilfield cased-hole logging engineer. Essentially
his work involved the underground injection of various radioactive
isotopes to obtain information on the best method to extract oil and
natural gas reserves. He was exposed to the following agents:
Iridium-192 10-20 mcuries (seldom used)
Cesium-137 3 curies (used 4-5 times/year)
Ammerisium-berylium 3-5 curies (used everytime a well was
logged, approximately 150-
200 times/yr)
Iodine-131 20 mcuries (In liquid form, 100
times/yr)
He describes the workers attitude towards radioactive hazards as
"cavalier". They used no protection whatsoever. Isotopes would
spill on clothing, blow into their faces etc. They would store them
in the trucks to prevent freezing. When the patient took a safety
course on radioisotopes, he recognized the danger and quit this line
of work!
He began to experience sharp retrosternal chest pain in 1981.
After being treated for everything you could possibly imagine, he
eventually had an open thoracotomy in 1989 at which time the tumour
was found and a tissue sample was taken. He has had courses of
radiotherapy and chemotherapy, his lesion is apparently unresectable.
There has been impingement on his SVC and a stent has been inserted.
He is aware that the cancer is terminal but, understandably, no one
has given him a time frame. He is being followed with CT Scans every
6 months.
We have been asked to comment on causation.
He says numerous other co-workers have had various types of
malignancy - 2 cases of leukemia, plus bowel, prostate, bladder,
testicle. Apparently several have had thyroid abnormalities but the
patient is unsure exactly what these are.
We are in the process of:
- Alerting our Dept of Labour to the situation
- Obtaining all his records
- Searching the literature
Any insight or help with this case the group could provide would
be most welcome.
Christopher Martin
Resident
Occupational Health Program
University of Alberta
Edmonton, Alberta
Received: from dudley.mc.duke.edu by mednet.med.miami.edu (SMTPLINK V2.11.01)
; Wed, 04 Sep 96 17:48:57 EST
Return-Path: <occ-env-med-l-owner@dudley.mc.duke.edu>
Received: (from daemon@localhost) by dudley.mc.duke.edu (8.7.3/8.6.10) id PAA03888 for occ-env-med-l-outgoing; Wed, 4 Sep 1996 15:15:05 -0400 (EDT)
From: CJMARTIN@PHS.Med.UAlberta.CA
Organization: Public Health Sciences, U Alberta
To: occ-env-med-l@list.mc.duke.edu
Date: Wed, 4 Sep 1996 13:16:47 MDT
Subject: OEM: Carcinoid tumour of thymus and radioisotope exposure
Priority: normal
X-mailer: Pegasus Mail v3.1 (R1a)
Message-ID: <B9B561777F7@phs.med.ualberta.ca>
Sender: owner-occ-env-med-l@list.mc.duke.edu
Precedence: bulk